NCT07217249View on ClinicalTrials.gov

Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years

NANot yet recruitingINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

December 30, 2025

Primary Completion Date

December 30, 2029

Study Completion Date

April 30, 2030

Conditions
Fuchs Endothelial Corneal DystrophyCorneal Endothelial Decompensation
Interventions
PROCEDURE

Descemet membrane endothelial keratoplasty

Replacement of the recipient corneal endothelial and Descemet membrane with healthy tissue from a donor cornea.

Trial Locations (5)

46260

Price Vision Group, Indianapolis

48105

University of Michigan/Kellogg Eye Center, Ann Arbor

49546

Verdier Eye Center, Grand Rapids

52242

University of Iowa Hospitals and Clinics, Iowa City

55905

Mayo Clinic, Rochester

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Case Western Reserve University

OTHER

NCT07217249 - Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years | Biotech Hunter | Biotech Hunter